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The most preferred treatment for acute periprosthetic joint infection (PJI) is surgical
debridement, antibiotics and retention of the implant (DAIR). The reported success of
DAIR varies greatly and depends on a complex interplay of several host-related factors,
duration of symptoms, the microorganism(s) causing the infection, its susceptibility to
antibiotics and many others. Thus, there is a great clinical need to predict failure of
the “classical” DAIR procedure so that this surgical option is offered to those most
likely to succeed, but also to identify those patients who may benefit from more
intensified antibiotic treatment regimens or new and innovative treatment strategies. In
this review article, the current recommendations for DAIR will be discussed, a summary
of independent risk factors for DAIR failure will be provided and the advantages and
limitations of the clinical use of preoperative risk scores in early acute (post-surgical)
and late acute (hematogenous) PJIs will be presented. In addition, the potential of
implementing machine learning (artificial intelligence) in identifying patients who are at
highest risk for failure of DAIR will be addressed. The ultimate goal is to maximally tailor
and individualize treatment strategies and to avoid treatment generalization.
Keywords: debridement, implant retention, risk score, machine learning, failure, periprosthetic joint infection

INTRODUCTION
Success rates of the “classical” debridement, antibiotics, irrigation and implant retention (DAIR)
for acute periprosthetic joint infections (PJI) vary widely, ranging from 30 to 90% (1–5). Apart
from a thorough surgical debridement with exchange of modular components, many factors
contribute to the success of DAIR; that includes shorter duration of symptoms, lack of patient
comorbidities, a low bacterial inoculum and/or degree of inflammation at clinical presentation, a
causative microorganism that is susceptible to antibiotics with anti-biofilm properties and many
others (6–25). For this reason, being able to identify a category of patients who are likely to
fail DAIR is essential, either to choose a different surgical procedure, to intensify antimicrobial
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treatment or to apply new innovative treatment strategies to
increase the chance of treatment success. In this overview we will
outline the current recommendations for DAIR treatment and
discuss the limitations of these recommendations. In addition,
we will address preoperative risk classification systems and the
potential of machine learning to predict DAIR failure. These
latter two show great potential to be used in clinical practice and
may aid in clinical decision making.

existing comorbidities may expose the patient to an increased risk
for complications and failure. In addition, as the microorganism
and its susceptibility to antibiotics is often not known prior to
surgery, these implant- and host-related factors are of utmost
importance to take into consideration.

WHO SHOULD RECEIVE DAIR
ACCORDING TO THE IDSA GUIDELINES

To identify patients who are likely to fail DAIR, two preoperative
risk scores have been proposed in literature; one for early acute
(post-surgical) and one for late acute (hematogenous) PJIs (8,
16). These risk scores include only those variables that are
known preoperatively without taking into account the causative
microorganism and its susceptibility to antibiotics, mimicking
the situation mostly encountered in clinical practice.

PREOPERATIVE RISK SCORES TO
PREDICT DAIR FAILURE

Since many different factors have been identified in literature
as independent predictors for DAIR failure (Table 1) (6–25),
it is a great challenge to select those patients who are the
best candidates for DAIR. According to the IDSA guidelines
published in 2013 (26), a DAIR is advised for patients with
acute PJI, defined as a symptom duration of <3 weeks or, in
case of early post-surgical infections, within 4 weeks of index
arthroplasty. In addition, the prosthesis needs to be well-fixed,
a sinus tract should be absent and the microorganism needs to be
susceptible to oral antimicrobial agents with anti-biofilm activity.
If these conditions are met, a DAIR is recommended, and in
other situations revision of the implant is advised. Although this
approach seems legitimate, it entails important limitations. First,
it excludes a large subgroup of patients that may still benefit
from DAIR. For example, in post-surgical cases it is advised
to remove the infected implant when the index arthroplasty
occurred more than 4 weeks ago. However, the process of
mature biofilm formation varies substantially according to the
type of causative microorganism and the inoculum size that
contaminates the joint during surgery (27, 28). To therefore,
exclude these patients as a candidate for a DAIR procedure is
not justified. Indeed, Löwik et al. demonstrated an acceptable
outcome of DAIR in patients presenting more than 4 weeks after
the index arthroplasty as long as DAIR was performed within 4
week after the onset of symptoms and modular components were
exchanged (29). In this category of patients, the prosthesis could
still be retained in around 80% of patients without the need for
life long suppressive antibiotic treatment. A second limitation of
the IDSA recommendation concerning the indication for DAIR
is the lack of distinction between early acute (post-surgical) and
late acute (hematogenous) PJIs. This distinction may be critical,
since several studies demonstrated a worse outcome in late acute
PJIs treated with DAIR compared to early acute PJIs, in particular
when caused by staphylococci (8, 13, 23, 30). Considering the
difference in pathogenesis, and the chance of continuous seeding
to the prosthetic joint in case of hematogenous infections (e.g.,
endocarditis), it is reasonable to assume that these infections
should be approached differently as well. A third limitation
of the IDSA guideline, is that the causative microorganism(s)
and its susceptibility to antibiotics are often not known prior
to surgery. A final limitation is the fact that implant- and
host-related factors are not included in the decision-making
model to determine appropriateness of DAIR. This may result
in misclassifying a patient as a good candidate for DAIR while

Frontiers in Medicine | www.frontiersin.org

KLIC-score for Early Acute (Post-Surgical)
PJI
In 2015, Tornero et al. published the KLIC-score as preoperative
risk score for predicting DAIR failure in early acute PJI (16).
The authors of this study examined a cohort of 222 patients
who were within 3 months after the index surgery and who
had no more than 3 weeks of symptoms prior to DAIR. DAIR
failure was defined as the need for a second DAIR, implant
removal, suppressive antibiotic treatment or infection-related
death within 60 days after the initial irrigation and debridement.
They analyzed in a univariate model several variables that
were known preoperatively, like host-related factors, duration
of symptoms, characteristics of the infected implant and serum
inflammatory parameters, and developed a risk stratification
score according to the beta-coefficients of the multivariate
analysis (Figure 1A). Chronic Kidney disease, Liver cirrhosis,
the Index surgery (revision surgery or prosthesis indicated for a
fracture), a Cemented prosthesis and a C-reactive protein > 115
mg/l (KLIC) appeared to be the most prominent preoperative
variables associated with failure. The score demonstrated 100%
DAIR failure when having a preoperative score of more than
six, and 4.5% when having a score lower than two. After this
publication, three additional studies from other institutions
validated the KLIC-score in their cohort of patients (18, 31, 32).
All three institutions demonstrated the predictive power of the
KLIC-score in patients with a very low or a very high score,
but the score was less useful in patients with average scores. In
addition, one study identified that other variables appeared to
be more predictive in their cohort of patients compared to those
defined in the KLIC (18), stressing the importance of differences
in local epidemiology when implementing risk scores from an
external cohort of patients.

CRIME80-score for Late Acute
(Hematogenous) PJI
Following the KLIC-score, Wouthuyzen-Bakker et al. performed
the same statistical analysis in a large multicenter cohort of 340
patients with late acute PJIs (8). Late acute PJI was defined
as the appearance of acute symptoms of infection occurring
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TABLE 1 | Summary of studies depicting independent predictors of DAIR failure in acute PJIs by using multivariate analysis.
Reference Author et al.

Year

N

(6)

2013

345

(7)

(8)

Lora-Tamayo

Lora-Tamayo

Wouthuyzen-Bakker

2017

2018

462

340

Host, implant and surgical
factors (known preoperatively)

aOR/aHR

2.23

Polymicrobial

1.77

Serum CRP

1.22

Levofloxacin and rifampina

0.42

Exchange modular components

0.65

Vancomycin and rifampinb

0.29

≥2 debridements

1.63

Bacteremia

1.81

Rheumatoid arthritis

2.36

S. aureus

3.52

S. aureus

0.59

Suboptimal antibiotic treatmentc

4.92

Ineffective empirical antibiotics

3.20

Revision prosthesis

1.37

Late post-surgical infection

2.20

Exchange modular components

0.60

Male sex

2.02

Age > 80 years

2.60

COPD

2.90

Rheumatoid Arthritis

5.13

Fracture

5.39

Serum CRP > 150 mg/L

2.00

Exchange modular components

0.35

Urish

2017

206

Symptoms > 7 days

1.68

(9)

Marculescu

2006

99

Sinus tract

2.84

Symptoms > 8 days

1.77

(48)

Tornero

2016

143

(12)

Puhto

2015

113

Leukocytes > 10 × 109 /L

3.70

(13)

Vilchez

2011

65

Late acute PJI

2.57

≥2 debridements

4.61

(14)

El Helou

2010

91

(15)

Martínez-Pastor

2009

47

Serum CRP > 150 mg/L

3.57

(16)

Tornero

2015

222

Chronic renal failure

5.92

Liver cirrhosis

4.46

Femoral neck fracture

4.39

Revision prosthesis

4.34

Cemented prosthesis

8.71

Serum CRP > 115 mg/L

12.3

(17)

Rodriguez-Pardo

2014

174

Chronic renal failure

2.56

(18)

Löwik

2018

386

Male sex

2.03

Left-sided prosthesis

1.80

Ischemic heart disease

1.84

Liver cirrhosis

12.4

(19)

Tornero

2014

160

Serum CRP > 120 mg/L

1.06

(20)

Bergkvist

2016

35

Hip fracture

8.30

(21)

Byren

2009

112

Revision prosthesis

3.10

Arthroscopic procedure

4.20

Vilchez

2011

53

(23)

Rodriguez

2010

50

(24)

Letouvet

2016

60

(25)

Soriano

2006

aOR/aHR

Immune suppressive drugs

(10)

(22)

Microorganism and antibiotics
(known postoperatively*)

Serum CRP > 220 mg/L

20.4

≥2 debridements

9.80

Number of prior surgeries

6.30

47

Rifampin in staphylococci PJI

0.11

No fluoroquinolone in Gram
negative

9.09

Fluoroquinolone in Gram negative

0.23

No fluoroquinolone in Gram
negative

6.5

S. aureus

2.9

S. aureus

5.3

S. aureus

9.4

Antibiotic treatment < 3 months

20.0

Enterococcus spp. or MRSA

17.6

*The presence of bacteremia, the causative microorganism and its susceptibility to antibiotics are sometimes known prior to DAIR, but in most cases not.
analysis of patients with a post-surgical PJI due to methicillin-susceptible S. aureus (MSSA).
b Sub-group analysis of patients with a post-surgical PJI due to methicillin-resistant S. aureus (MRSA).
c No rifampin for Gram positives and no fluoroquinolone for Gram negatives.
CRP, C-reactive protein; COPD, Chronic Obstructive Pulmonary Disease.

a Sub-group
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FIGURE 1 | Preoperative risk scores for DAIR failure. KLIC-score for predicting DAIR failure in early acute (postsurgical) PJI (A) and CRIME80-score for predicting
DAIR failure in late acute (hematogenous) PJI (B).

Potential of Machine Learning (Artificial
Intelligence) in Predicting DAIR Failure

more than 3 months after the index arthroplasty, in a prior
asymptomatic prosthetic joint. Patients with a sinus tract and/or
patients with symptoms existing for longer than 3 weeks before
DAIR were excluded. In contrast to the study of Tornero et al.,
a second DAIR procedure was not considered as failure, and
failure could occur even 60-days after the initial debridement.
In addition, the authors also included the exchange of mobile
components as a valid preoperative variable, as the possibility to
exchange it can be known prior to surgery as well. According
to this analysis, Chronic obstructive pulmonary disease, a Creactive protein > 150 mg/L, Rheumatoid arthritis, fracture
as Indication for the prosthesis, Male sex, not Exchanging
the mobile components and an age > 80 years (CRIME80),
were the strongest preoperative variables associated with failure
(Figure 1B). The strength of prediction of the CRIME80-score
was lower than the KLIC-score, starting with a baseline failure
rate of 22%, and increasing to 79% with a score higher than four.
It is important to note that the isolation of Staphylococcus aureus
was one of the major predictors of failure in the late acute cohort.
When S. aureus was the causative microorganism, the baseline
failure rate was 43%, and the preoperative variables turned out
to be less predictive in these cases. For this reason, the authors
stress the importance of isolating the microorganism prior to
deciding the surgical procedure. Unlike the KLIC-score, the
CRIME80-score has not yet been validated in an external cohort
of patients.

Frontiers in Medicine | www.frontiersin.org

Considering the complex interplay of factors associated with
DAIR failure, regular statistical methods lack the finesse for
more accurate and individualized predictions. The advantage
of machine learning over regular statistical methods, like
multivariate analysis, is its ability to actually learn from data
input. Where multivariate analysis examines the correlation
of variables and the strength of these correlations, machine
learning learns from observations by using decision trees. The
subsequently created algorithm is then able to process new
input that has not been seen before. By this means, machine
learning models are able to process more complex data, and
by building precision models they are able to make more
accurate predictions. Machine learning has become more and
more popular in infection management (33). Recently, Shohat
et al. used random forest analysis as a machine learning
model to predict DAIR failure (34). The authors of this study
analyzed more than 1,000 patients that underwent irrigation and
debridement of a hip or knee prosthesis for acute PJI. The created
algorithm had good discriminatory power, with an area under
the curve of 0.74. Cross-validation, a model validation technique
assessing the ability to process an independent dataset, showed
similar probabilities, indicating a high accuracy of the model.
Although the model still needs to be validated in an external
cohort of patients, the created algorithm has great potential
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When a DAIR has been performed in a patient with a
low preoperative risk score for failure, but the infection turns
out to be caused by a microorganism that is resistant to
biofilm active drugs, antibiotic duotherapy can be considered,
particularly during the initial period. Adding fosfomycin to the
antibiotic regimen as a second drug in infections with multidrug
resistant Gram negatives or Gram positive microorganisms, or
adding daptomycin for Gram positive infections, have shown
great promise: both of the latter antibiotics have shown good
antibiofilm properties in vitro and in vivo when used as part
of a combination treatment (39–45). An alternative option is
life-long antibiotic suppressive therapy, especially if patients are
not eligible for additional surgery. According to a recent large
multicenter cohort study with a follow-up period of 5 years, PJI
can be controlled with antibiotic suppressive therapy in around
50% of cases (46). Another alternative strategy would be to
apply new and more innovative treatments to control infection,
like applying subcutaneous antibiotics for patients who do not
tolerate oral antibiotics or for infections caused by multidrug
resistant bacteria that lack an oral alternative. This proof of
concept was demonstrated by Ferry et al. and was successful in
6 out of 10 patients (47). Considering the low chance of success
for both treatment strategies, isolating the microorganism prior
to surgery and choosing for implant removal in high risk patients
would be preferable.

to be used in daily practice by easily entering patient data
in a computer-based software or smartphone application, and
may aid in clinical decision making and patient counseling. As
the causative microorganism is of great influence on treatment
outcome (7, 8), the authors of this study decided to include this
variable in the analysis as well. Although its inclusion improves
its predictive power, the microorganism needs to be entered to
ensure the highest accuracy of the model, and thus, ideally should
be known prior to surgery. The same holds for the presence or
absence of bacteremia.

TO TAILOR AND INDIVIDUALIZE
TREATMENT STRATEGIES
The described preoperative risk scores and machine learning
model, can be applied in daily clinical practice, and may aid
in the decision making process. When a patient has a high
a priori risk for DAIR failure, immediate implant removal
should be considered; not only to avoid surgery that is very
likely to fail, but also to reduce the adverse effect of DAIR on
subsequent surgical procedures (35, 36). Wouthuyzen-Bakker
et al. analyzed the treatment outcome of immediate implant
removal vs. DAIR in late acute PJIs by matching patients
according to their preoperative CRIME80 score (37). The authors
found that implant removal resulted in 83% treatment success
in patients with a CRIME80 score ≥ 3, while the success was
only 35% when treated with DAIR. No clear difference was
observed between one- and two-stage exchange arthroplasties.
Although a high CRIME80 score was logically associated with the
presence of more comorbidities and old age, immediate implant
removal was associated with a lower—instead of higher—
mortality rate compared to DAIR. These data suggest that
immediate implant removal is safe, even though the surgery in
general is more aggressive.
A promising technique to potentially increase the success
rate of DAIR, especially for difficult to treat microorganisms
(e.g., multidrug resistant Gram negatives or rifampin resistant
staphylococci), is to locally inject a selected cocktail of
bacteriophages during surgery. Although future studies are
needed to endorse this practice, its clinical success has been
described as salvage therapy in relapsing S. aureus PJI (38).
A main disadvantage though, is that the microorganism(s)
causing the infection not only needs to be known prior to
surgery, but the corresponding targeted bacteriophages need to
be produced in the laboratory, before they can be applied. Since
delaying DAIR increases the risk of treatment failure, the use of
bacteriophage therapy for this indication is therefore, probably
less feasible.

CONCLUSION
Selecting those patients who are good candidates for a DAIR
procedure is essential. Current IDSA recommendations for DAIR
entail important limitations, and tools that also take into account
other variables that are associated with DAIR failure are needed.
Preoperative risk scores like the KLIC-score for early acute (postsurgical) and CRIME80-score for late acute (hematogenous)
PJI could be helpful, especially when the microorganism is not
known prior to surgery. In addition, machine learning shows
great potential to predict failure more accurately compared to
regular statistical methods. Implementing the aforementioned
tools in daily care will help physicians tailor and individualize
treatment strategies. Both described risk classification systems
as well as the recently published machine learning model need
clinical evaluation in larger external cohorts of patients to
validate its predictive power.
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